Premier, Inc. (PINC)

$22.42

+0.19

(+0.85%)▲

Market is closed - opens 8 PM, 22 Nov 2024

Performance

  • $22.20
    $22.50
    $22.42
    downward going graph

    1.0%

    Downside

    Day's Volatility :1.36%

    Upside

    0.36%

    downward going graph
  • $17.96
    $23.43
    $22.42
    downward going graph

    19.92%

    Downside

    52 Weeks Volatility :23.37%

    Upside

    4.31%

    downward going graph

Returns

PeriodPremier, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
11.71%
-6.9%
0.0%
6 Months
16.05%
-1.7%
0.0%
1 Year
6.66%
10.4%
0.0%
3 Years
-44.21%
8.8%
-24.1%

Highlights

Market Capitalization
2.1B
Book Value
$19.98
Dividend Share
0.84
Dividend Yield
3.78%
Earnings Per Share (EPS)
1.39
PE Ratio
15.99
PEG Ratio
1.63
Wall Street Target Price
21.25
Profit Margin
10.98%
Operating Margin TTM
15.44%
Return On Assets TTM
4.46%
Return On Equity TTM
6.4%
Revenue TTM
1.3B
Revenue Per Share TTM
12.16
Quarterly Revenue Growth YOY
-7.8%
Gross Profit TTM
896.3M
EBITDA
380.9M
Diluted Eps TTM
1.39
Quarterly Earnings Growth YOY
0.88
EPS Estimate Current Year
2.18
EPS Estimate Next Year
2.22
EPS Estimate Current Quarter
0.25
EPS Estimate Next Quarter
0.29

Analyst Recommendation

Hold
    43%Buy
    50%Hold
    6%Sell
Based on 16 Wall street analysts offering stock ratings for Premier, Inc.(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
8
8
7
Sell
1
1
1

Analyst Forecast

What analysts predicted

Downside of 5.22%

Current $22.42
Target $21.25

Company Financials

FY19Y/Y Change
Revenue
1.2B
↓ 26.7%
Net Income
334.7M
↑ 905.01%
Net Profit Margin
27.49%
↑ 25.49%
FY20Y/Y Change
Revenue
1.3B
↑ 6.73%
Net Income
291.1M
↓ 13.01%
Net Profit Margin
22.4%
↓ 5.09%
FY21Y/Y Change
Revenue
1.7B
↑ 32.44%
Net Income
287.5M
↓ 1.24%
Net Profit Margin
16.71%
↓ 5.69%
FY22Y/Y Change
Revenue
1.4B
↓ 16.75%
Net Income
265.9M
↓ 7.53%
Net Profit Margin
18.55%
↑ 1.84%
FY23Y/Y Change
Revenue
1.3B
↓ 6.76%
Net Income
175.0M
↓ 34.17%
Net Profit Margin
13.1%
↓ 5.45%
FY24Y/Y Change
Revenue
1.3B
↑ 0.77%
Net Income
119.5M
↓ 31.7%
Net Profit Margin
8.88%
↓ 4.22%
Q2 FY23Q/Q Change
Revenue
340.4M
↑ 5.63%
Net Income
21.5M
↓ 54.14%
Net Profit Margin
6.31%
↓ 8.21%
Q3 FY23Q/Q Change
Revenue
318.8M
↓ 6.35%
Net Income
44.8M
↑ 108.55%
Net Profit Margin
14.04%
↑ 7.73%
Q4 FY23Q/Q Change
Revenue
334.7M
↑ 5.02%
Net Income
54.3M
↑ 21.32%
Net Profit Margin
16.22%
↑ 2.18%
Q1 FY24Q/Q Change
Revenue
342.6M
↑ 2.35%
Net Income
-40.2M
↓ 174.02%
Net Profit Margin
-11.73%
↓ 27.95%
Q2 FY24Q/Q Change
Revenue
350.3M
↑ 2.24%
Net Income
60.7M
↓ 250.95%
Net Profit Margin
17.32%
↑ 29.05%
Q3 FY24Q/Q Change
Revenue
248.1M
↓ 29.16%
Net Income
70.8M
↑ 16.66%
Net Profit Margin
28.53%
↑ 11.21%
FY19Y/Y Change
Total Assets
2.6B
↑ 11.13%
Total Liabilities
3.4B
↓ 8.22%
FY20Y/Y Change
Total Assets
2.9B
↑ 14.75%
Total Liabilities
2.8B
↓ 18.14%
FY21Y/Y Change
Total Assets
3.5B
↑ 19.48%
Total Liabilities
1.3B
↓ 53.97%
FY22Y/Y Change
Total Assets
3.4B
↓ 4.71%
Total Liabilities
1.1B
↓ 14.29%
FY23Y/Y Change
Total Assets
3.4B
↑ 0.43%
Total Liabilities
1.0B
↓ 6.42%
FY24Y/Y Change
Total Assets
3.4B
↑ 1.69%
Total Liabilities
1.5B
↑ 41.39%
Q2 FY23Q/Q Change
Total Assets
3.4B
↓ 4.02%
Total Liabilities
1.0B
↓ 11.86%
Q3 FY23Q/Q Change
Total Assets
3.8B
↑ 14.18%
Total Liabilities
1.5B
↑ 44.33%
Q4 FY23Q/Q Change
Total Assets
3.8B
↓ 0.44%
Total Liabilities
1.4B
↓ 3.64%
Q1 FY24Q/Q Change
Total Assets
3.4B
↓ 12.23%
Total Liabilities
1.4B
↓ 0.13%
Q2 FY24Q/Q Change
Total Assets
3.4B
↑ 1.93%
Total Liabilities
1.5B
↑ 1.8%
Q3 FY24Q/Q Change
Total Assets
3.3B
↓ 3.35%
Total Liabilities
1.4B
↓ 7.29%
FY19Y/Y Change
Operating Cash Flow
505.3M
↓ 0.47%
Investing Cash Flow
-129.5M
↑ 39.7%
Financing Cash Flow
-387.2M
↓ 7.67%
FY20Y/Y Change
Operating Cash Flow
349.5M
↓ 30.83%
Investing Cash Flow
-222.3M
↑ 71.72%
Financing Cash Flow
-169.0M
↓ 56.37%
FY21Y/Y Change
Operating Cash Flow
407.4M
↑ 16.56%
Investing Cash Flow
-174.6M
↓ 21.48%
Financing Cash Flow
-203.0M
↑ 20.15%
FY22Y/Y Change
Operating Cash Flow
444.2M
↑ 9.04%
Investing Cash Flow
-139.4M
↓ 20.12%
Financing Cash Flow
-347.8M
↑ 71.33%
FY23Y/Y Change
Operating Cash Flow
444.5M
↑ 0.07%
Investing Cash Flow
-273.6M
↑ 96.23%
Financing Cash Flow
-167.3M
↓ 51.91%
Q2 FY23Q/Q Change
Operating Cash Flow
113.4M
↓ 15.68%
Investing Cash Flow
-23.8M
↑ 6.81%
Financing Cash Flow
-91.2M
↓ 20.85%

Technicals Summary

Sell

Neutral

Buy

Premier, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Premier, Inc.
Premier, Inc.
12.04%
16.05%
6.66%
-44.21%
-38.59%
Solventum Corp
Solventum Corp
-4.1%
12.51%
0.77%
0.77%
0.77%
Doximity, Inc.
Doximity, Inc.
13.85%
71.25%
95.76%
-18.73%
-9.43%
Veeva Systems Inc.
Veeva Systems Inc.
-2.28%
4.27%
22.1%
-26.54%
39.98%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-8.18%
1.71%
11.41%
35.56%
35.56%
Healthequity Inc
Healthequity Inc
19.45%
31.7%
56.73%
72.24%
71.7%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Premier, Inc.
Premier, Inc.
15.99
15.99
1.63
2.18
0.06
0.04
0.04
19.98
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
57.36
57.36
2.42
0.9
0.19
0.12
NA
5.15
Veeva Systems Inc.
Veeva Systems Inc.
56.02
56.02
1.21
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.26
23.26
2.12
4.28
0.22
0.06
0.0
18.2
Healthequity Inc
Healthequity Inc
85.8
85.8
1.12
2.19
0.05
0.03
NA
24.7
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Premier, Inc.
Premier, Inc.
Hold
$2.1B
-38.59%
15.99
10.98%
Solventum Corp
Solventum Corp
Hold
$10.8B
0.77%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$9.3B
-9.43%
57.36
33.69%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$34.1B
39.98%
56.02
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$38.8B
35.56%
23.26
8.56%
Healthequity Inc
Healthequity Inc
Buy
$9.0B
71.7%
85.8
9.61%

Insights on Premier, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 350.26M → 248.14M (in $), with an average decrease of 29.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -40.19M → 70.78M (in $), with an average increase of 90.3% per quarter

  • Vs DOCS

    In the last 1 year, Doximity, Inc. has given 95.8% return, outperforming this stock by 89.1%

  • Vs HQY

    In the last 3 years, Premier, Inc. has experienced a drawdown of -44.2%, however Healthequity Inc resisted the overall trend and outperformed by 25.5%

Institutional Holdings

  • BlackRock Inc

    14.72%

  • Vanguard Group Inc

    11.92%

  • Pacer Advisors, INC.

    6.57%

  • Dimensional Fund Advisors, Inc.

    6.13%

  • Bank of America Corp

    4.43%

  • Morgan Stanley - Brokerage Accounts

    4.29%

Corporate Announcements

  • Premier, Inc. Dividends March,2024

    In the quarter ending March,2024. Premier, Inc. has declared dividend of $0.21

    Read More

Company Information

as a leading national healthcare solutions organization, premier, inc. collaborates with healthcare organizations to improve supply chain management, decrease healthcare costs, integrate data and improve the health of communities. as an industry leader, premier has created one of the most comprehensive database of actionable data, best practices and cost reduction strategies. we enable our members to collaborate easily and efficiently improve their quality outcomes, while reducing costs. by engaging members and revealing new opportunities, we empower our alliance to improve performance like no one else in healthcare can.

Organization
Premier, Inc.
Employees
2900
CEO
Mr. Michael J. Alkire
Industry
Health Services

FAQs